Geode Capital Management LLC Buys 31,572 Shares of Milestone Scientific Inc. (NYSE:MLSS)

Geode Capital Management LLC increased its stake in Milestone Scientific Inc. (NYSE:MLSSFree Report) by 6.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 527,005 shares of the company’s stock after buying an additional 31,572 shares during the quarter. Geode Capital Management LLC owned about 0.68% of Milestone Scientific worth $480,000 as of its most recent SEC filing.

Separately, Y Intercept Hong Kong Ltd purchased a new stake in shares of Milestone Scientific in the third quarter worth approximately $48,000. Institutional investors own 5.79% of the company’s stock.

Milestone Scientific Price Performance

Milestone Scientific stock opened at $1.18 on Monday. The stock has a market cap of $91.91 million, a price-to-earnings ratio of -16.85 and a beta of 1.10. The firm has a 50-day moving average of $0.86 and a two-hundred day moving average of $0.89. Milestone Scientific Inc. has a 1 year low of $0.54 and a 1 year high of $1.27.

Insider Activity at Milestone Scientific

In related news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the sale, the director now directly owns 4,606,882 shares in the company, valued at $4,284,400.26. The trade was a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 24.75% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

MLSS has been the subject of a number of recent analyst reports. Benchmark restated a “speculative buy” rating and set a $1.25 price objective on shares of Milestone Scientific in a report on Wednesday, November 20th. StockNews.com assumed coverage on Milestone Scientific in a research report on Monday. They set a “hold” rating for the company.

View Our Latest Analysis on Milestone Scientific

Milestone Scientific Company Profile

(Free Report)

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

See Also

Want to see what other hedge funds are holding MLSS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Milestone Scientific Inc. (NYSE:MLSSFree Report).

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.